New Enterprise Associates 17, L.P. bought KRRO

March 10, 2026 · Form 4 insider transaction

New Enterprise Associates 17, L.P. bought 207,100 shares of Korro Bio, Inc. at $11.11 per share, a transaction worth $2.30M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
207,100
Price
$11.11
Total value
$2.30M
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMarch 10, 2026
Filing dateMarch 12, 2026
Shares owned after1,297,893
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Acquired from the Issuer on March 10, 2026 pursuant to a Subscription Agreement dated March 9, 2026.; The securities are directly held by New Enterprise Associates 17, L.P. ("NEA 17") and are indirectly held by NEA Partners 17, L.P. ("NEA Partners 17"), the sole general partner of NEA 17, NEA 17 GP, LLC ("NEA 17 GP"), the sole general partner of NEA Partners 17, and the individual managers of NEA 17 GP (NEA Partners 17, NEA 17 GP and the individual managers of NEA 17 GP (collectively, the "Managers") together, the "Indirect Reporting Persons"). The Mangers are Forest Baskett, Ali Behbahani, Carmen Chang, Anthony Florence, Jr., Mohamad Makhzoumi, Edward Mathers, Scott Sandell, Paul Walker and Rick Yang. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Indirect Reporting Persons have no pecuniary interest.

View the original Form 4 on SEC EDGAR